Lee J N, Salem H T, Al-Ani A T, Chard T, Huang S C, Ouyang P C, Wei P Y, Seppälä M
Am J Obstet Gynecol. 1981 Mar 15;139(6):702-4. doi: 10.1016/0002-9378(81)90490-7.
Serum levels of human chorionic gonadotropin (hCG), pregnancy-specific beta-1-glycoprotein (SP1), and placental protein 5 (PP5) were measured prior to treatment in 14 patient with hydatidiform mole and in nine patients with choriocarcinoma. Measurement of circulating levels of SP1 and PP5, but not hCG, provides a distinction between benign and malignant gestational trophoblastic tumors.
在对14例葡萄胎患者和9例绒毛膜癌患者进行治疗前,检测了血清中人绒毛膜促性腺激素(hCG)、妊娠特异性β1-糖蛋白(SP1)和胎盘蛋白5(PP5)的水平。检测循环中的SP1和PP5水平而非hCG水平,可区分良性和恶性妊娠滋养细胞肿瘤。